Real-time enrollment status for this resectable pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 3:01 PM UTC
| NCT Number | NCT07645651 |
| Recruiting Status | Recruiting |
| Condition | Resectable Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 15 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Washington |
| Last Updated on CT.gov | August 20, 2026 (2 weeks ago) |
As of September 3, 2026: Clinical trial NCT07645651 is currently recruiting participants. This phase1 study for resectable pancreatic ductal adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Washington. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07645651 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07645651 was last updated 2 weeks ago (August 20, 2026). HelloStudys verifies this status automatically.